UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Aaron Lee(Imperial College London), Adnan Tufail(Moorfields Eye Hospital), Thomas Butt(University College London), Gerald Liew(The University of Sydney), Usha Chakravarthy(Queen's University Belfast), Martin McKibbin(Leeds Teaching Hospitals NHS Trust), Louise Downey(Hull and East Yorkshire Hospitals NHS Trust), Catherine Egan(Maine Farmland Trust), Salim Natha(Wrightington, Wigan and Leigh NHS Foundation Trust), R J Antcliff(Royal United Hospital Bath NHS Trust), Marie Tsaloumas(University Hospitals Birmingham NHS Foundation Trust), Cecilia S. Lee(University of Washington), Catey Bunce(Moorfields Eye Hospital NHS Foundation Trust), Dawn A. Sim(Moorfields Eye Hospital NHS Foundation Trust), Atul Varma(Mid Yorkshire Hospitals NHS Trust), Vineeth Kumar(National Institute of Ocean Technology), Rehna Khan(Calderdale and Huddersfield NHS Foundation Trust), Kaveri Mandal(Warrington and Halton Teaching Hospitals NHS Foundation Trust), Robert L. Johnston(Cheltenham General Hospital), Wen Xing(Moorfields Eye Hospital NHS Foundation Trust), Pearse A. Keane(University College London), Toks Akerele(Hinchingbrooke Health Care NHS Trust), Clare Bailey(Bristol Eye Hospital)
Cited by 60
Related Papers
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
|BMC Ophthalmology|2010|830
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
|Ophthalmology Retina|2017|669